On November 3, 2021 MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, reported that the Company’s management will participate in the following conferences in November and December 2021 (Press release, MacroGenics, NOV 3, 2021, View Source [SID1234594240]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Credit Suisse 30th Annual Healthcare Conference. MacroGenics’ management will participate in one-on-one meetings and provide a corporate overview on Tuesday, November 9, 2021 at 8:00 am ET.
Stifel 2021 Virtual Healthcare Conference. MacroGenics’ management is scheduled to participate in a fireside chat on Tuesday, November 16, 2021 at 8:00 am ET, and will also participate in one-on-one meetings.
Evercore ISI 4th Annual HealthCONx Virtual Conference. MacroGenics’ management is scheduled to participate in a fireside chat on Thursday, December 2, 2021 at 8:25 am ET, and will also participate in one-on-one meetings.
JMP Securities Hematology and Oncology Summit. MacroGenics’ management is scheduled to participate in a fireside chat on Monday, December 6, 2021 at 1:00 pm ET, and will also participate in one-on-one meetings.
Webcasts of the above presentations may be accessed under "Events & Presentations" in the Investor Relations section of MacroGenics’ website at View Source The Company will maintain archived replays of these webcasts on its website for 30 days after each conference.